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Palliative care is the active improvement in
quality of life and relief of suffering for
patients with incurable disease.1 Despite
being recognised as a human right by the
WHO,1 the United Nations Committee on
Economic, Social and Cultural Rights2 and
the International Covenant for Economic,
Social and Cultural Rights,3 4 there are sig-
niﬁcant disparities in the worldwide provi-
sion of palliative care services for individuals
with life-limiting illnesses. Of the 40 million
people globally in need of palliative care, just
14% receive it, most of whom are adults and
children in high-income countries (HICs).5 6
For the millions of individuals who die
without palliative care, largely in low-income
countries, end of life is typically marked by
pain and suffering. This is due in part to the
unavailability of oral analgesia7–10 but also
more generally, to the fragility of health
systems in low-resource settings.11 Particular
barriers to the integration of palliative care
in low-resource settings include lack of aware-
ness by policymakers, health professionals
and the public, of what palliative care is and
the beneﬁts it can offer patients and health
systems. Additional barriers include cultural
and social beliefs about death and dying,
misconceptions that palliative care is only for
patients with cancer, for those in their last
days or weeks of life, and ﬁnally, the miscon-
ception that improving access to opioid anal-
gesia could lead to increased substance
abuse.
Cost of illness (COI) represents the total
economic burden of a disease on society and
is comprised of direct and indirect costs.
Direct costs measure the resources used to
treat illness (staff time, radiotherapy, chemo-
therapy, advanced imaging) while indirect
costs usually measure lost productivity (the
patient or family member taking time off
of work or school).12 In HIC, dramatic
increases in COI are common as the incur-
able disease progresses. In these settings,
palliative care offers a resource-sparing alter-
native while simultaneously improving quality
of life.13–17 Due in large part to this
empirical evidence and the established cost-
effectiveness of palliative care in some HIC,
the provision of palliative care in these loca-
tions has continued to increase over the past
several decades.18
Far less well understood is the COI of
incurable diseases in low-resource settings.
The authors have worked in palliative care in
low-income and middle-income countries
(LMICs) over the past 20 years. LG estab-
lished one of the ﬁrst rural hospital-based
palliative care services in Kenya at Chogoria
Hospital in the 1990s, and has led many
research programmes on integration of
palliative care into health systems in
sub-Saharan Africa. REA is a Global Health
fellow studying the value of global palliative
care as a poverty reduction strategy.
Fragile health systems lack the safety nets
of health insurance schemes, social support
programmes and critically, palliative care ser-
vices for patients with incurable disease. This
Summary box
▸ Palliative care is a human right, yet there are sig-
nificant disparities in the worldwide provision of
palliative care services for individuals with life-
limiting illness. Of the 40 million people globally
in need of palliative care, just 14% receive it,
largely in high-income countries.
▸ While proven to be ‘cost-effective’ in high-
income settings based on principles of cost
avoidance, the costs of illness for incurable
disease in low-resource settings is largely
unknown.
▸ The critical absence of palliative care services in
low-resource settings results in significant costs
being absorbed by the individual, family and
local community. This results in intractable, dev-
astating and perpetuating financial losses that
are passed on to future generations and function
as a catalyst in the poverty cycle while stunting
local economic growth.
▸ In considering the direct, indirect and broader
societal costs of incurable disease in low-
resource countries, palliative care should be
considered as a poverty-reduction strategy.
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results in tremendous costs of care that are inevitably
absorbed by the individual, family and local community.
For example, in a cohort of patients with cancer in
Ethiopia, we found that reported medical costs, includ-
ing medications, treatments and travel to health facil-
ities, necessitated the sale of livestock, homes, wedding
gold, as well as pulling children from school as the fees
became unaffordable. In studies conducted in Malawi,
Kenya, Rwanda, Uganda and Zambia, we identiﬁed that
families prioritised the immediate need to seek for cures
for their ill family member over saving funds for future
household costs. The reluctance of clinical staff to break
bad news about illness progression and prognosis con-
tributed to this prioritisation of a search for a cure.
We have observed staggering direct and indirect costs
of care for incurable disease in LMIC, which ultimately
result in intractable, devastating and perpetuating ﬁnan-
cial losses that are passed on to future generations.
Examples of direct costs include out-of-pocket expenses
for medical visits, procedures, purchase of medications
and transportation, any of which individually may be
greater than a monthly salary. Homes, livestock, wedding
gold and other important assets are often sold to pay for
the direct costs of medical care. Understandably, the
sale of these assets may cause a family struggling with
poverty to slip into destitution.19
Indirect costs are harder to measure but comprise a
signiﬁcant burden of the cost of care for patients, their
families and local communities. Common sources are
missed wages from the patient who is too ill to work and
often a second lost wage from the family member
staying with the patient to provide care. Other indirect
costs include a reduction in future earning potential
due to the sale of assets such as livestock and farmland,
to cope with direct costs, and lost opportunities for
young people who are pulled out of school at a young
age to care for ill adults or because school fees become
unaffordable due to medical expenses. These factors
have a negative impact not just on family wealth but also
on the local economy.20
In small-scale economies, material wealth strongly pre-
dicts the wealth of offspring via intergenerational wealth
transfer. Ultimately, when parents lose their wealth to
medical costs, future generations are gravely affected:
small-scale economies lack the potential for important
individual earnings over a lifetime—the most signiﬁcant
form of wealth is inherited.21
The poverty cycle is a phenomenon by which impover-
ished families remain impoverished for three or more
generations because they lack the resources necessary to
exit the cycle. This is most often because they have used
these resources to pay for expenses such as a death or
illness. The lack of ﬁnancial resources parallels a lack of
other capital, such as educational and social connec-
tions, which in turn pushes the family even further into
poverty.22 This has been shown to be true for chronic
disease in LMICs, where the constant care and treat-
ment required, and the length of illness (years rather
than days) reduces the patient and families’ capacity to
purchase adequate drugs, or to earn money working.
Indeed, similarities exist between the chronic disease
economic model and that for incurable disease: chronic
disease simultaneously destroys the internal family
resources and stunts local economic growth.4 The WHO
has conceded that “existing knowledge underestimates
the implications of chronic diseases for poverty and the
potential that chronic disease prevention and health
promotion have for alleviating poverty in low and
middle income countries.”23 They conclude that invest-
ment in chronic disease prevention programmes is
essential to reduce poverty. We propose that investing in
palliative care is just as essential to reducing poverty in
LMICs. Similar to chronic disease, patients with incur-
able disease also face substantial costs, and the lack of
access to palliative care services in these settings func-
tions as a catalyst in the poverty cycle.
Global cancer care is perhaps the best example of a
rigorous health economic model adapted and applied
to LMICs.24 Strategies such as prevention, screening,
capacity building and treatment form the cornerstones.
Similarly rigorous economic models for palliative care
delivery in LMICs are lacking, with most models from
HICs where palliative care has been shown to be cost-
effective based on the principle of cost avoidance (avoid-
ing expensive, non-beneﬁcial therapies at end of life).
Yet this model fails in low-resource settings where the
alternative is no care. The potential beneﬁt palliative
care can offer patients, their children, grandchildren
and local economy lies in mitigation of the costs of
illness and suffering, rather than avoidance of costs of
expensive treatment.25 On a societal level, palliative care
can serve as a health system expander in offering
patients with incurable disease the possibility of care
within their homes, thereby reserving hospital-based
care, with its limited resource of nurses, doctors and sup-
plies for patients with potentially reversible illness.
Hand-in-hand with the lack of economic models for
sustainable and cost-effective delivery of palliative care is
buy-in from leading international global health institu-
tions. The African Palliative Care Association is actively
working to increase palliative care delivery and address
the deﬁciency in regional and national palliative care
policies.26 However, until palliative care is globally recog-
nised as a sustainable, cost-effective intervention, it will
not be recognised as a priority goal, and will continue to
be underdeveloped and underfunded in the face of
escalating need.
Though many LMICs have inverted pyramids with sig-
niﬁcant numbers of young people, there are also many
nations with rising numbers of elderly who are living
longer than ever. Non-communicable diseases, including
cancer, are rising fastest in low-resource settings.27
Chronic disease, incurable disease and disability have
become a reality for millions, and there has never been
a more opportune time to invest in planning and devel-
opment strategies to help care for them.
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Through the tireless efforts of many visionaries
working to strengthen palliative care and the 2014 World
Health Assembly Resolution there has been an increase
in palliative care services, yet need far outweighs supply,
and supply still remains too heavily dependent on exter-
nal funding rather than integrated health sector expend-
iture. It is difﬁcult to think about putting an actual
economic value on the relief of human suffering. Yet this
ﬁnancial estimate is necessary to ultimately promote the
expansion and longevity of palliative care services in
LMICs. Demonstrating the economic value of palliative
care in LMICs, through the development of a health eco-
nomic model for delivery, is key to sustainability. This in
turn is crucial to guiding healthcare policy and gaining
momentum for increasing government-sponsored and
locally run palliative care services. Our group is actively
engaging health economists with international palliative
care providers and consultants to construct this model.
We believe that it is more costly not to have palliative care
in low-resource settings, and that when palliative care ser-
vices are incorporated into the health system, they can
be delivered for minimal ﬁnancial cost but enormous
physical, emotional and social beneﬁt per patient.
Therefore, coordinated, international funding should
focus on the widespread development and integration of
palliative care services within local health systems, secur-
ing this human right for all.
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